China's WuXi AppTec has named three new executives: Brian Xu is made vice president of toxicology and head of the firm's safety evaluation centre at Suzhou; Yang-Dar Yuan has been appointed VP of operations and head of pathology at the centre; and Robert Coldreck joined the company as head of good laboratory practice quality assurance.
French drugmaker Sanofi-Aventis has named Jerome Contamine as chief financial officer. Sanofi’s chief executive, Chris Viehbacher, said Mr Contamine "will be deeply be involved in the simplification of ... operational structures."
US-based Enzo Biochem has named Kevin Krenitsky as president of its Enzo Clinical Labs subsidiary, a clinical reference laboratory. Krenitsky replaces Shahram Rabbani and joins the firm from Bioserve Biotechnologies.
Discovery toxicology specialist Cellumen has named industry veteran and former Pfizer executive Dr. Jack Reynolds to its board of directors. He is the founder of J A Reynolds & Associates, which advises on improving safety testing and decision making in the pharmaceutical industry.
Christina Shasserre has been appointed global head of bioscience at Germany’s Merck KGaA, effective immediately.
US drug major Eli Lilly has appointed Alex Azar to the position of vice president, business-to-business and Puerto Rico. Azar was formerly Deputy Secretary of Health and Human Services.
Marketing and communications consultancy Makovsky & Co has named Marian Cutler as senior vice president in its health practice.
The US Department of Health and Human Services has appointed David Blumenthal as the National Coordinator for Health Information Technology. Dr. Blumenthal was previously director of the Institute for Health Policy at the Massachusetts General Hospital and Partners Health Care System in Boston.
Management consultancy Metaplan has appointed Alexandra Wendt to its New Jersey practice. She will help Metaplan to implement web-based moderation and survey technology.